Agilent Technologies, Inc. (A) Financial Ratios
28 years of historical data (1998–2025) · Healthcare · Medical - Diagnostics & Research
EV/EBITDA
↓
19.74
↓-17% vs avg
5yr avg: 23.82
30Y Low6.1·High31.3
P/FCF
↓
28.92
↓-11% vs avg
5yr avg: 32.48
30Y Low8.8·High40.7
P/B Ratio
↓
4.96
↓-28% vs avg
5yr avg: 6.93
30Y Low0.9·High9.0
ROE
↓
20.6%
-8% vs avg
5yr avg: 22.4%
30Y Low-55%·High85%
Debt/EBITDA
↑
1.90
+9% vs avg
5yr avg: 1.74
30Y Low0.1·High13.9
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
A Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Agilent Technologies, Inc. trades at 25.8x earnings, 19% below its 5-year average of 31.8x, sitting at the 52nd percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 16%. On a free-cash-flow basis, the stock trades at 28.9x P/FCF, 11% below the 5-year average of 32.5x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $33.3B | $41.6B | $37.9B | $30.6B | $41.5B | $48.3B | $31.9B | $24.1B | $21.1B | $22.2B | $14.3B |
| Enterprise Value | $34.9B | $43.1B | $40.2B | $31.7B | $43.2B | $49.6B | $32.8B | $25.1B | $20.6B | $21.5B | $13.9B |
| P/E Ratio → | 25.75 | 32.03 | 29.42 | 24.67 | 33.10 | 39.97 | 44.39 | 22.48 | 66.79 | 32.40 | 31.12 |
| P/S Ratio | 4.79 | 5.98 | 5.82 | 4.48 | 6.06 | 7.65 | 5.97 | 4.67 | 4.29 | 4.96 | 3.41 |
| P/B Ratio | 4.96 | 6.17 | 6.43 | 5.23 | 7.82 | 8.97 | 6.54 | 5.07 | 4.61 | 4.59 | 3.38 |
| P/FCF | 28.92 | 36.08 | 27.62 | 20.76 | 40.65 | 37.31 | 39.72 | 27.85 | 23.14 | 31.10 | 21.92 |
| P/OCF | 21.37 | 26.66 | 21.66 | 17.27 | 31.63 | 32.56 | 34.58 | 23.59 | 19.37 | 24.95 | 18.08 |
P/E links to full P/E history page with 30-year chart
A EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Agilent Technologies, Inc.'s enterprise value stands at 19.7x EBITDA, 17% below its 5-year average of 23.8x. The Healthcare sector median is 14.1x, placing the stock at a 40% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 6.21 | 6.17 | 4.65 | 6.31 | 7.85 | 6.14 | 4.86 | 4.19 | 4.81 | 3.32 |
| EV / EBITDA | 19.74 | 24.41 | 23.02 | 19.58 | 22.34 | 29.73 | 28.40 | 21.30 | 18.50 | 20.39 | 16.18 |
| EV / EBIT | 23.58 | 27.88 | 24.84 | 22.14 | 27.22 | 34.42 | 35.62 | 25.29 | 20.18 | 24.39 | 22.65 |
| EV / FCF | — | 37.44 | 29.25 | 21.53 | 42.33 | 38.27 | 40.86 | 29.03 | 22.65 | 30.17 | 21.33 |
A Profitability
Margins and return-on-capital ratios measuring operating efficiency
Agilent Technologies, Inc. earns an operating margin of 21.3%. Operating margins have expanded from 19.8% to 21.3% over the past 3 years, signaling improving operational efficiency. ROE of 20.6% indicates solid capital efficiency. ROIC of 13.5% represents solid returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 52.4% | 52.4% | 54.3% | 50.7% | 54.4% | 53.9% | 53.1% | 54.3% | 54.7% | 53.9% | 52.3% |
| Operating Margin | 21.3% | 21.3% | 22.9% | 19.8% | 23.6% | 21.3% | 15.8% | 18.2% | 18.4% | 18.8% | 14.6% |
| Net Profit Margin | 18.8% | 18.8% | 19.8% | 18.1% | 18.3% | 19.1% | 13.5% | 20.7% | 6.4% | 15.3% | 10.9% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 20.6% | 20.6% | 22.0% | 22.2% | 23.5% | 23.6% | 14.9% | 23.0% | 6.7% | 15.1% | 10.9% |
| ROA | 10.6% | 10.6% | 11.4% | 11.6% | 11.8% | 11.9% | 7.5% | 11.9% | 3.7% | 8.4% | 6.0% |
| ROIC | 13.5% | 13.5% | 14.7% | 14.5% | 17.8% | 16.3% | 11.0% | 14.3% | 16.4% | 15.7% | 12.0% |
| ROCE | 14.5% | 14.5% | 15.6% | 15.1% | 18.3% | 15.7% | 10.9% | 12.8% | 12.4% | 12.0% | 9.2% |
A Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Agilent Technologies, Inc. carries a Debt/EBITDA ratio of 1.9x, which is manageable (42% below the sector average of 3.3x). Net debt stands at $1.6B ($3.4B total debt minus $1.8B cash). Interest coverage of 13.2x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.50 | 0.50 | 0.61 | 0.47 | 0.52 | 0.51 | 0.48 | 0.51 | 0.39 | 0.42 | 0.45 |
| Debt / EBITDA | 1.90 | 1.90 | 2.05 | 1.69 | 1.43 | 1.64 | 2.04 | 2.04 | 1.61 | 1.91 | 2.21 |
| Net Debt / Equity | — | 0.23 | 0.38 | 0.20 | 0.32 | 0.23 | 0.19 | 0.22 | -0.10 | -0.14 | -0.09 |
| Net Debt / EBITDA | 0.89 | 0.89 | 1.29 | 0.71 | 0.89 | 0.75 | 0.80 | 0.87 | -0.40 | -0.63 | -0.45 |
| Debt / FCF | — | 1.36 | 1.64 | 0.78 | 1.68 | 0.96 | 1.14 | 1.18 | -0.49 | -0.94 | -0.59 |
| Interest Coverage | 13.21 | 13.21 | 15.50 | 14.21 | 19.26 | 16.63 | 10.85 | 12.72 | 12.05 | 10.65 | 8.54 |
A Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.96x means Agilent Technologies, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 1.52x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 2.61x to 1.96x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.96 | 1.96 | 2.09 | 2.61 | 2.03 | 2.22 | 2.33 | 1.53 | 3.29 | 3.30 | 3.85 |
| Quick Ratio | 1.52 | 1.52 | 1.57 | 1.97 | 1.47 | 1.74 | 1.84 | 1.21 | 2.74 | 2.85 | 3.28 |
| Cash Ratio | 0.76 | 0.76 | 0.70 | 0.99 | 0.57 | 0.92 | 0.98 | 0.66 | 1.92 | 2.12 | 2.42 |
| Asset Turnover | — | 0.55 | 0.55 | 0.63 | 0.65 | 0.59 | 0.55 | 0.55 | 0.58 | 0.53 | 0.54 |
| Inventory Turnover | 3.22 | 3.22 | 3.00 | 3.27 | 3.01 | 3.51 | 3.48 | 3.47 | 3.49 | 3.59 | 3.76 |
| Days Sales Outstanding | — | 78.12 | 74.23 | 68.96 | 74.89 | 67.70 | 70.96 | 65.75 | 57.64 | 59.09 | 54.81 |
A Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Agilent Technologies, Inc. returns 2.1% to shareholders annually — split between a 0.8% dividend yield and 1.3% buyback yield. The payout ratio of 21.6% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 3.9% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.8% | 0.7% | 0.7% | 0.9% | 0.6% | 0.5% | 0.7% | 0.9% | 0.9% | 0.8% | 1.0% |
| Payout Ratio | 21.6% | 21.6% | 21.3% | 21.4% | 19.9% | 19.5% | 30.9% | 19.2% | 60.4% | 24.9% | 32.6% |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.9% | 3.1% | 3.4% | 4.1% | 3.0% | 2.5% | 2.3% | 4.4% | 1.5% | 3.1% | 3.2% |
| FCF Yield | 3.5% | 2.8% | 3.6% | 4.8% | 2.5% | 2.7% | 2.5% | 3.6% | 4.3% | 3.2% | 4.6% |
| Buyback Yield | 1.3% | 1.0% | 3.0% | 1.9% | 2.7% | 1.6% | 1.5% | 3.0% | 2.0% | 0.9% | 3.0% |
| Total Shareholder Yield | 2.1% | 1.7% | 3.8% | 2.7% | 3.3% | 2.1% | 2.2% | 3.9% | 2.9% | 1.6% | 4.1% |
| Shares Outstanding | — | $284M | $291M | $296M | $300M | $307M | $312M | $318M | $325M | $326M | $329M |
Peer Comparison
Compare A with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 AYou | $33B | 25.8 | 19.7 | 28.9 | 52.4% | 21.3% | 20.6% | 13.5% | 1.9 |
 WAT | $23B | 32.5 | 21.5 | 42.2 | 57.8% | 28.2% | 29.3% | 20.3% | 1.3 |
 TMO | $176B | 26.7 | 19.0 | 27.9 | 37.7% | 18.2% | 13.1% | 7.5% | 3.8 |
 DHR | $124B | 34.7 | 18.1 | 23.5 | 60.9% | 20.9% | 7.1% | 5.9% | 2.4 |
 BRKR | $6B | -282.0 | 17.9 | 148.7 | 45.9% | 6.9% | -0.4% | 4.4% | 4.5 |
 MTD | $27B | 31.5 | 23.5 | 31.8 | 57.5% | 27.8% | — | 40.0% | 1.9 |
 BIO | $7B | 9.3 | 16.8 | 18.7 | 52.0% | 10.5% | 10.8% | 2.6% | 3.2 |
 RGEN | $7B | 146.2 | 52.2 | 75.5 | 47.1% | 8.1% | 2.4% | 2.2% | 5.0 |
 IDXX | $46B | 44.3 | 32.1 | 43.8 | 61.8% | 31.6% | 66.2% | 42.5% | 0.7 |
 ILMN | $22B | 26.2 | 20.1 | 23.3 | 66.7% | 19.9% | 33.4% | 16.8% | 2.3 |
 CRL | $9B | -62.5 | 13.0 | 17.3 | 30.5% | 12.6% | -4.3% | 6.3% | 3.4 |
| Healthcare Median | — | 22.1 | 14.1 | 18.7 | 63.9% | -5.3% | -33.7% | -10.8% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 28 years · Updated daily
Full A Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See A's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs A Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare A vs WAT
Side-by-side business, growth, and profitability comparison vs Waters Corporation.
Start ComparisonA — Frequently Asked Questions
Quick answers to the most common questions about buying A stock.
What is Agilent Technologies, Inc.'s P/E ratio?
Agilent Technologies, Inc.'s current P/E ratio is 25.8x. The historical average is 26.2x. This places it at the 52th percentile of its historical range.
What is Agilent Technologies, Inc.'s EV/EBITDA?
Agilent Technologies, Inc.'s current EV/EBITDA is 19.7x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 17.8x.
What is Agilent Technologies, Inc.'s ROE?
Agilent Technologies, Inc.'s return on equity (ROE) is 20.6%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 14.3%.
Is A stock overvalued?
Based on historical data, Agilent Technologies, Inc. is trading at a P/E of 25.8x. This is at the 52th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What is Agilent Technologies, Inc.'s dividend yield?
Agilent Technologies, Inc.'s current dividend yield is 0.84% with a payout ratio of 21.6%.
What are Agilent Technologies, Inc.'s profit margins?
Agilent Technologies, Inc. has 52.4% gross margin and 21.3% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
How much debt does Agilent Technologies, Inc. have?
Agilent Technologies, Inc.'s Debt/EBITDA ratio is 1.9x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.